News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
派格生物醫藥(02565.HK)創新候選產品CR059入選ADA最新突破性摘要
派格生物醫藥－Ｂ(02565.HK)公布，集團自主研發的創新候選產品CR059相關研究摘要獲美國糖尿病協會(ADA)2026年科學年會接收，並入選最新突破性摘要，將以海報形式展示。根據相關研究結果，CR059展現出顯著減重效果、突出的降糖表現及長期表達特徵，並顯示出作為長效代謝疾病治療方案的開發潛力。(de/d)~阿思達克財經新聞網址: www.aastoc...
Reset
Send
The window will close in 5 seconds
派格生物醫藥(02565.HK)創新候選產品CR059入選ADA最新突破性摘要
Close
Recommend
2
Positive
1
Negative
2
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

派格生物醫藥－Ｂ(02565.HK)  -1.500 (-3.030%)    Short selling $356.42K; Ratio 1.514%   公布，集團自主研發的創新候選產品CR059相關研究摘要獲美國糖尿病協會(ADA)2026年科學年會接收，並入選最新突破性摘要，將以海報形式展示。

根據相關研究結果，CR059展現出顯著減重效果、突出的降糖表現及長期表達特徵，並顯示出作為長效代謝疾病治療方案的開發潛力。(de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-09 16:25.)

AASTOCKS新聞

Switch to Auto-Translated Version
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.